4//SEC Filing
Oakes Gregory 4
Accession 0001415889-21-000255
CIK 0001604191other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:48 PM ET
Size
5.4 KB
Accession
0001415889-21-000255
Insider Transaction Report
Form 4
Oakes Gregory
Director
Transactions
- Award
Options (right to buy)
2021-01-04+41,237→ 41,237 totalExercise: $0.97Exp: 2031-01-03→ Common stock, par value $0.0001 per share (41,237 underlying)
Footnotes (1)
- [F1]The options vest in equal quarterly installments on each of March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001809796
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:48 PM ET
- Size
- 5.4 KB